Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Uterine Cervical Neoplasms 1Rectal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Oropharyngeal Neoplasms 1Lymphoma, Follicular 1Leukemia, Hairy Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Burkitt Lymphoma 1Anus Neoplasms 1

Interventions

Cisplatin 11Specimen Handling 9Magnetic Resonance Spectroscopy 9pembrolizumab 6durvalumab 6Platinum 61,2-diaminocyclohexaneplatinum II citrate 6cemiplimab 5Carboplatin 5Radiation 4Cetuximab 4Biopsy 4poly ICLC 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Pemetrexed 3Paclitaxel 3Nivolumab 3Docetaxel 3(225)Ac-DOTA-c(RGDyK) 3ipatasertib 2cabozantinib 2atezolizumab 2Oxaliplatin 2Ipilimumab 2Immunoglobulin G 2Fluorouracil 2Disulfides 2Capecitabine 2ALT-803 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Diphenhydramine × 30 days × Clear all
NCT05977998 2026-05-22

A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology

M.D. Anderson Cancer Center

Phase 2 Recruiting
30 enrolled
Tumor-Agnostic

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡